About Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:DXTR
CUSIPN/A
Phone+1-650-3649975
Debt
Debt-to-Equity RatioN/A
Current Ratio0.47%
Quick Ratio0.37%
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$3.42 million
Price / Sales0.55
Cash FlowN/A
Price / CashN/A
Book Value($0.21) per share
Price / Book-0.19
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$-17,220,000.00
Net Margins-402.96%
Return on EquityN/A
Return on Assets-195.83%
Miscellaneous
Employees50
Outstanding Shares48,210,000
Dextera Surgical (NASDAQ:DXTR) Frequently Asked Questions
What is Dextera Surgical's stock symbol?
Dextera Surgical trades on the NASDAQ under the ticker symbol "DXTR."
How were Dextera Surgical's earnings last quarter?
Dextera Surgical Inc (NASDAQ:DXTR) issued its earnings results on Thursday, November, 9th. The medical instruments supplier reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.02. The medical instruments supplier earned $0.69 million during the quarter, compared to analyst estimates of $0.62 million. View Dextera Surgical's Earnings History.
When is Dextera Surgical's next earnings date?
What price target have analysts set for DXTR?
2 analysts have issued 12-month target prices for Dextera Surgical's stock. Their predictions range from $0.70 to $0.80. On average, they anticipate Dextera Surgical's share price to reach $0.75 in the next twelve months. View Analyst Ratings for Dextera Surgical.
Who are some of Dextera Surgical's key competitors?
Some companies that are related to Dextera Surgical include Rex Energy (REXX), Avinger (AVGR), STRATA Skin Sciences (SSKN), Inpixon (INPX), Westmoreland Coal (WLB), Orexigen Therapeutics (OREX), Sorrento Tech (ROKA), Argos Therapeutics (ARGS), Rosetta Genomics (ROSG), Recon Capital Series Trust Recon Capital FTSE 100 ETF (UK), Global Brokerage (GLBR), Great Basin Scientific (GBSN), Rand Logistics (RLOG), 1st Century Bancshares (FCTY), Accelrys (ACCL), Acme Packet (APKT), Actuate (BIRT) and Adept Technology (ADEP).
Who are Dextera Surgical's key executives?
Dextera Surgical's management team includes the folowing people:
- Robert Y. Newell IV, Principal Executive Officer, Chief Financial Officer, Vice President - Finance (Age 67)
- Michael A. Bates, Director (Age 57)
- Julian Nikolchev, Director (Age 62)
Has Dextera Surgical been receiving favorable news coverage?
Media stories about DXTR stock have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Dextera Surgical earned a media sentiment score of 0.07 on Accern's scale. They also gave media headlines about the medical instruments supplier an impact score of 45.59 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.
How do I buy shares of Dextera Surgical?
Shares of DXTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Dextera Surgical's stock price today?
One share of DXTR stock can currently be purchased for approximately $0.0389.
How big of a company is Dextera Surgical?
Dextera Surgical has a market capitalization of $3.02 million and generates $3.42 million in revenue each year. Dextera Surgical employs 50 workers across the globe.
How can I contact Dextera Surgical?
Dextera Surgical's mailing address is 900 Saginaw Dr, REDWOOD CITY, CA 94063-4753, United States. The medical instruments supplier can be reached via phone at +1-650-3649975 or via email at [email protected]
MarketBeat Community Rating for Dextera Surgical (DXTR)
MarketBeat's community ratings are surveys of what our community members think about Dextera Surgical and other stocks. Vote "Outperform" if you believe DXTR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DXTR will underperform the S&P 500 over the long term. You may vote once every thirty days.
Dextera Surgical (NASDAQ:DXTR) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
2 Wall Street analysts have issued ratings and price targets for Dextera Surgical in the last 12 months. Their average twelve-month price target is $0.75, suggesting that the stock has a possible upside of 1,828.02%. The high price target for DXTR is $0.80 and the low price target for DXTR is $0.70. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
Consensus Rating: | Buy | Buy | Buy | Buy |
Consensus Rating Score: | 3.00 | 3.00 | 3.00 | 3.00 |
Ratings Breakdown: | 0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 0 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s) |
Consensus Price Target: | $0.75 | $0.75 | $0.75 | $0.75 |
Price Target Upside: | 1,828.02% upside | 200.00% upside | 200.00% upside | 200.00% upside |
Dextera Surgical (NASDAQ:DXTR) Consensus Price Target History

Dextera Surgical (NASDAQ:DXTR) Analyst Ratings History
Show:
Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
---|
8/16/2017 | Ladenburg Thalmann | Initiated Coverage | Buy -> Buy | $0.80 | High |  |
7/12/2017 | Wedbush | Lower Price Target | Outperform | $3.50 -> $0.70 | High |  |
(Data available from 4/22/2016 forward)
Dextera Surgical (NASDAQ:DXTR) Dividend History by Quarter
Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
---|
(Data available from 1/1/2013 forward)
Dextera Surgical (NASDAQ DXTR) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 10.43%
Institutional Ownership Percentage: 4.49%
Dextera Surgical (NASDAQ DXTR) Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
5/16/2016 | Thomas J Palermo | COO | Buy | 6,300 | $2.62 | $16,506.00 | 8,100 | |
2/29/2016 | Michael A Bates | Director | Buy | 35,400 | $3.53 | $124,962.00 | 74,600 | |
2/26/2016 | Thomas J Palermo | COO | Buy | 7,500 | $3.77 | $28,275.00 | 7,500 | |
2/24/2016 | Michael A Bates | Director | Buy | 26,600 | $2.99 | $79,534.00 | 23,000 | |
2/23/2016 | Julian Nikolchev | Insider | Buy | 1,146 | $2.60 | $2,979.60 | 6,464 | |
2/23/2016 | Michael A Bates | Director | Buy | 5,000 | $2.63 | $13,150.00 | 23,000 | |
2/22/2016 | Julian Nikolchev | Insider | Buy | 2,696 | $2.60 | $7,009.60 | 6,464 | |
2/22/2016 | Michael A Bates | Director | Buy | 2,000 | $2.62 | $5,240.00 | 23,000 | |
2/19/2016 | Michael A Bates | Director | Buy | 1,000 | $2.53 | $2,530.00 | 21,000 | |
2/12/2016 | Robert Y. Iv Newell | CFO | Buy | 40,000 | $0.26 | $10,400.00 | | |
2/11/2016 | Julian Nikolchev | Insider | Buy | 37,680 | $0.27 | $10,173.60 | 37,680 | |
2/9/2016 | Gregory P Watson | VP | Buy | 75,000 | $0.25 | $18,750.00 | 75,000 | |
11/24/2014 | Gary S Petersmeyer | Director | Buy | 25,000 | $0.60 | $15,000.00 | | |
11/24/2014 | Robert Y Iv Newell | CFO | Buy | 20,000 | $0.60 | $12,000.00 | | |
11/13/2014 | Robert Y Iv Newell | CFO | Buy | 10,000 | $0.87 | $8,700.00 | | |
11/10/2014 | William H Younger Jr | Director | Buy | 34,354 | $0.91 | $31,262.14 | | |
5/23/2014 | Jeffrey Purvin | Director | Buy | 5,000 | $0.95 | $4,750.00 | | |
5/22/2014 | Robert Y Iv Newell | CFO | Buy | 10,000 | $0.95 | $9,500.00 | | |
11/21/2013 | Bernard A Hausen | CEO | Buy | 5,500 | $0.95 | $5,225.00 | | |
11/18/2013 | Robert Y Iv Newell | CFO | Buy | 10,000 | $0.95 | $9,500.00 | | |
3/20/2013 | Hill Ventures Sutter | Major Shareholder | Buy | 981,736 | $1.05 | $1,030,822.80 | | |
3/20/2013 | Robert Y Iv Newell | CFO | Buy | 8,000 | $1.05 | $8,400.00 | | |
3/20/2013 | William H Younger Jr | Director | Buy | 1,244,678 | $1.05 | $1,306,911.90 | | |
(Data available from 1/1/2013 forward)
Dextera Surgical (NASDAQ DXTR) News Headlines
Source: |
|
Date | Headline |
---|
 | Dextera Surgical Inc (DXTR) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - April 10 at 11:21 PM |
 | Comparing Dextera Surgical (DXTR) & Nanosphere (NSPH) www.americanbankingnews.com - March 30 at 9:20 PM |
 | Head-To-Head Survey: Cynosure (CYNO) & Dextera Surgical (DXTR) www.americanbankingnews.com - March 30 at 5:21 AM |
 | Critical Survey: Dextera Surgical (DXTR) versus Alliance HealthCare Services (AIQ) www.americanbankingnews.com - March 26 at 9:32 AM |
 | Comparing Zeltiq Aesthetics (ZLTQ) & Dextera Surgical (DXTR) www.americanbankingnews.com - March 20 at 11:20 PM |
 | Analyzing Cynosure (CYNO) and Dextera Surgical (DXTR) www.americanbankingnews.com - March 19 at 5:16 PM |
 | Dextera Surgical Inc (DXTR) Given Consensus Rating of "Hold" by Analysts www.americanbankingnews.com - March 18 at 3:14 AM |
 | Financial Contrast: Dextera Surgical (DXTR) vs. Koninklijke Philips (PHG) www.americanbankingnews.com - March 17 at 3:06 AM |
 | Dextera Surgical Obtains Approval for Asset Sale to Aesculap, Inc. finance.yahoo.com - February 5 at 9:25 AM |
![[$$] Aesculap to Acquire Bankrupt Surgical Stapler Maker Dextera [$$] Aesculap to Acquire Bankrupt Surgical Stapler Maker Dextera](/images/news-sites/YahooFinance.jpg) | [$$] Aesculap to Acquire Bankrupt Surgical Stapler Maker Dextera finance.yahoo.com - January 23 at 10:33 AM |
 | Zacks: Dextera Surgical Inc (DXTR) Given Consensus Recommendation of "Hold" by Analysts www.americanbankingnews.com - January 23 at 5:06 AM |
 | Analyzing Accelerate Diagnostics (AXDX) & Dextera Surgical (DXTR) www.americanbankingnews.com - January 19 at 9:34 PM |
 | Dextera Surgical Inc (DXTR) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - January 18 at 9:36 PM |
![[$$] Firm Retention Summary: Dextera Surgical Inc. [$$] Firm Retention Summary: Dextera Surgical Inc.](/images/news-sites/YahooFinance.jpg) | [$$] Firm Retention Summary: Dextera Surgical Inc. finance.yahoo.com - January 9 at 9:22 AM |
 | Dextera Surgical Inc (DXTR) Given $0.40 Consensus Target Price by Analysts www.americanbankingnews.com - December 24 at 1:28 AM |
 | Dextera Surgical (DXTR) & Luminex (LMNX) Head to Head Survey www.americanbankingnews.com - December 22 at 1:24 PM |
 | Dextera Surgical (DXTR) Files for Chapter 11 Bankruptcy www.streetinsider.com - December 13 at 9:35 AM |
 | Dextera Surgical (DXTR) Rating Increased to Hold at Zacks Investment Research www.americanbankingnews.com - December 12 at 9:28 PM |
 | Dextera Surgical Files For Bankruptcy - Quick Facts www.nasdaq.com - December 12 at 5:57 PM |
![[$$] Dextera Surgical Files for Bankruptcy With $17.3 Million Buyout Offer From Aesculap [$$] Dextera Surgical Files for Bankruptcy With $17.3 Million Buyout Offer From Aesculap](/images/news-sites/YahooFinance.jpg) | [$$] Dextera Surgical Files for Bankruptcy With $17.3 Million Buyout Offer From Aesculap finance.yahoo.com - December 12 at 5:57 PM |
 | Dextera Surgical (DXTR) Files for Chapter 11 Bankruptcy - StreetInsider.com www.streetinsider.com - December 12 at 9:48 AM |
 | Zacks: Analysts Anticipate Dextera Surgical Inc (DXTR) to Announce -$0.06 EPS www.americanbankingnews.com - December 7 at 3:36 PM |
 | Reviewing Dextera Surgical (DXTR) & Thoratec (THOR) www.americanbankingnews.com - December 3 at 11:40 PM |
 | Breakfast Technical Briefing on Medical Supplies Stocks -- Endologix, Dextera Surgical, Becton, Dickinson, and Ekso Bionics www.bizjournals.com - November 21 at 6:17 PM |
 | $880,000.00 in Sales Expected for Dextera Surgical Inc. (DXTR) This Quarter www.americanbankingnews.com - November 21 at 6:46 AM |
 | -$0.06 EPS Expected for Dextera Surgical Inc. (DXTR) This Quarter www.americanbankingnews.com - November 19 at 7:12 PM |
 | Dextera Surgical Inc. (DXTR) Sees Significant Decrease in Short Interest www.americanbankingnews.com - November 12 at 1:32 AM |
 | Dextera Surgical Inc. (DXTR) Releases Earnings Results, Misses Expectations By $0.02 EPS www.americanbankingnews.com - November 10 at 7:32 PM |
 | Dextera Surgical, Inc. to Host Earnings Call finance.yahoo.com - November 10 at 11:34 AM |
 | Dextera Surgical Reports Fiscal 2018 First Quarter Financial Results finance.yahoo.com - November 10 at 11:34 AM |
 | Dextera Surgical to Cancel Fiscal 2018 First Quarter Financial Results Conference Call on Thursday November 9, 2017 finance.yahoo.com - November 9 at 1:22 AM |
 | Why Dextera Surgical Inc’s (DXTR) Investor Composition Impacts Your Returns finance.yahoo.com - November 3 at 6:29 PM |
 | Zacks: Brokerages Anticipate Dextera Surgical Inc. (DXTR) Will Announce Quarterly Sales of $620,000.00 www.americanbankingnews.com - November 1 at 2:32 PM |
 | Dextera Surgical to Announce Fiscal 2018 First Quarter Financial Results on Thursday November 9, 2017 finance.yahoo.com - October 30 at 6:47 PM |
 | Dextera Surgical Inc. (DXTR) to Release Quarterly Earnings on Monday www.americanbankingnews.com - October 30 at 9:14 AM |
 | MedTech Growing on Emerging Markets, M&A: Stocks to Buy finance.yahoo.com - October 25 at 7:47 PM |
 | Tech Stocks to Keep on Your Radar finance.yahoo.com - October 20 at 7:35 PM |
 | Dextera Surgical (DXTR) & Its Peers Critical Analysis www.americanbankingnews.com - October 17 at 10:36 AM |
 | Dextera Surgical Inc. (DXTR) Expected to Post Quarterly Sales of $620,000.00 www.americanbankingnews.com - October 13 at 1:48 PM |
 | Brokers Set Expectations for Dextera Surgical Inc.'s FY2018 Earnings (DXTR) www.americanbankingnews.com - October 12 at 1:54 PM |
 | Zacks: Analysts Anticipate Dextera Surgical Inc. (DXTR) Will Announce Earnings of -$0.06 Per Share www.americanbankingnews.com - October 11 at 4:30 AM |
 | Dextera Surgical Inc. (DXTR) Upgraded to "Hold" by Zacks Investment Research www.americanbankingnews.com - October 11 at 12:04 AM |
 | Dextera Surgical (DXTR) Says MicroCutter 5/80 and Cardiac Anastomotic Devices to Be Featured at EACTS www.streetinsider.com - October 10 at 6:14 AM |
 | Reviewing Dextera Surgical (DXTR) & Varian Medical Systems (VAR) www.americanbankingnews.com - October 10 at 4:28 AM |
 | Dextera Surgical (DXTR) Says MicroCutter 5/80 and Cardiac Anastomotic Devices to Be Featured at EACTS - StreetInsider.com www.streetinsider.com - October 9 at 6:27 PM |
 | Dextera Surgical’s MicroCutter 5/80™ and Cardiac Anastomotic Devices to Be Featured at the 31st Annual European Association for Cardio-Thoracic Surgery finance.yahoo.com - October 9 at 6:27 PM |
 | Dextera Surgical (DXTR) Says it Working to Resolve Issues; Plans to Explore All Strategic Options - StreetInsider.com www.streetinsider.com - October 7 at 3:42 PM |
 | Edited Transcript of DXTR earnings conference call or presentation 5-Oct-17 12:30pm GMT finance.yahoo.com - October 5 at 10:18 PM |
 | Dextera Surgical Inc. (DXTR) Sees Large Increase in Short Interest www.americanbankingnews.com - September 30 at 3:26 AM |
 | Dextera Surgical Hosts Hands-on Training Course for Video-Assisted Thoracic Surgery Techniques Using MicroCutter ... - Business Wire (press release) www.businesswire.com - September 28 at 9:04 AM |
Dextera Surgical (NASDAQ:DXTR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Dextera Surgical (NASDAQ:DXTR) Income Statement, Balance Sheet and Cash Flow Statement
Dextera Surgical (NASDAQ DXTR) Stock Chart for Sunday, April, 22, 2018
Loading chart…